Correlation Between Petros Pharmaceuticals and China Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Petros Pharmaceuticals and China Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petros Pharmaceuticals and China Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Petros Pharmaceuticals and China Pharma Holdings, you can compare the effects of market volatilities on Petros Pharmaceuticals and China Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petros Pharmaceuticals with a short position of China Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petros Pharmaceuticals and China Pharma.

Diversification Opportunities for Petros Pharmaceuticals and China Pharma

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Petros and China is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and China Pharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Pharma Holdings and Petros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petros Pharmaceuticals are associated (or correlated) with China Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Pharma Holdings has no effect on the direction of Petros Pharmaceuticals i.e., Petros Pharmaceuticals and China Pharma go up and down completely randomly.

Pair Corralation between Petros Pharmaceuticals and China Pharma

Given the investment horizon of 90 days Petros Pharmaceuticals is expected to under-perform the China Pharma. In addition to that, Petros Pharmaceuticals is 1.01 times more volatile than China Pharma Holdings. It trades about -0.09 of its total potential returns per unit of risk. China Pharma Holdings is currently generating about -0.04 per unit of volatility. If you would invest  46.00  in China Pharma Holdings on August 28, 2024 and sell it today you would lose (26.00) from holding China Pharma Holdings or give up 56.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Petros Pharmaceuticals  vs.  China Pharma Holdings

 Performance 
       Timeline  
Petros Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Petros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
China Pharma Holdings 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in China Pharma Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, China Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Petros Pharmaceuticals and China Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Petros Pharmaceuticals and China Pharma

The main advantage of trading using opposite Petros Pharmaceuticals and China Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petros Pharmaceuticals position performs unexpectedly, China Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Pharma will offset losses from the drop in China Pharma's long position.
The idea behind Petros Pharmaceuticals and China Pharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets